BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32143495)

  • 1. Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer.
    Darwis NDM; Oike T; Kawamura H; Kawahara M; Kubo N; Sato H; Miyasaka Y; Katoh H; Ishikawa H; Matsui H; Miyazawa Y; Ito K; Suzuki K; Gondhowiardjo S; Nakano T; Ohno T
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32143495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer.
    Takakusagi Y; Oike T; Kano K; Anno W; Tsuchida K; Mizoguchi N; Serizawa I; Yoshida D; Katoh H; Kamada T
    PLoS One; 2020; 15(11):e0241636. PubMed ID: 33156884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
    Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP
    Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials.
    Roy S; Loblaw A; Cheung P; Chu W; Chung HT; Vesprini D; Ong A; Chowdhury A; Panjwani D; Pang G; Korol R; Davidson M; Ravi A; McCurdy B; Helou J; Zhang L; Mamedov A; Deabreu A; Quon HC
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):621-629. PubMed ID: 31126725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
    Romesser PB; Pei X; Shi W; Zhang Z; Kollmeier M; McBride SM; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):59-67. PubMed ID: 29254782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival.
    Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Radiat Oncol; 2017 Jun; 12(1):98. PubMed ID: 28615058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy.
    Hackett C; Ghosh S; Sloboda R; Martell K; Lan L; Pervez N; Pedersen J; Yee D; Murtha A; Amanie J; Usmani N
    J Contemp Brachytherapy; 2014 Oct; 6(3):247-53. PubMed ID: 25337125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis.
    Darwis NDM; Oike T; Kubo N; Gondhowiardjo SA; Ohno T
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.
    Feigenberg SJ; Hanlon AL; Horwitz EM; Uzzo RG; Eisenberg D; Pollack A
    Am J Clin Oncol; 2006 Oct; 29(5):458-62. PubMed ID: 17023779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of prostate-specific antigen bounce after 125I brachytherapy for prostate cancer.
    Kubo K; Wadasaki K; Kimura T; Murakami Y; Kajiwara M; Teishima J; Matsubara A; Nagata Y
    J Radiat Res; 2018 Sep; 59(5):649-655. PubMed ID: 30085076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.
    Kim DN; Straka C; Cho LC; Lotan Y; Yan J; Kavanagh B; Raben D; Cooley S; Brindle J; Xie XJ; Pistenmaa D; Timmerman R
    Pract Radiat Oncol; 2017; 7(1):e43-e49. PubMed ID: 27637137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-Specific Antigen Bounce after
    Kim TH; Lee JJB; Cho J
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer.
    Sheinbein C; Teh BS; Mai WY; Grant W; Paulino A; Butler EB
    Urology; 2010 Sep; 76(3):728-33. PubMed ID: 19616279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics differences between PSA bounce and biochemical failure in patients treated with 125I prostate brachytherapy.
    Kanzaki H; Kataoka M; Nishikawa A; Uwatsu K; Nagasaki K; Nishijima N; Hashine K
    Jpn J Clin Oncol; 2015 Jul; 45(7):688-94. PubMed ID: 25888709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer.
    Hauck CR; Ye H; Chen PY; Gustafson GS; Limbacher A; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):108-114. PubMed ID: 28586946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good prognosis following a PSA bounce after high dose rate brachytherapy and external radiotherapy in prostate cancer.
    Åström L; Sandin F; Holmberg L
    Radiother Oncol; 2018 Dec; 129(3):561-566. PubMed ID: 30193693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
    Critz FA; Williams WH; Levinson AK; Benton JB; Schnell FJ; Holladay CT; Shrake PD
    J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer.
    Kole TP; Chen LN; Obayomi-Davies O; Kim JS; Lei S; Suy S; Dritschilo A; Collins SP
    Acta Oncol; 2015 Jun; 54(6):832-8. PubMed ID: 25467965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.
    Patel C; Elshaikh MA; Angermeier K; Ulchaker J; Klein EA; Chehade N; Wilkinson DA; Reddy CA; Ciezki JP
    Urology; 2004 Jan; 63(1):110-3. PubMed ID: 14751360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator.
    Engeler DS; Schwab C; Thöni AF; Hochreiter W; Prikler L; Suter S; Stucki P; Schiefer J; Plasswilm L; Schmid HP; Putora PM
    Strahlenther Onkol; 2015 Oct; 191(10):787-91. PubMed ID: 26100965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.